{
    "abstract": "Leptomeningeal dissemination (LMD) is the primary cause of treatment failure in children with group 3 medulloblastoma (MB). Building on our previous work on protein phosphatase 2A (PP2A) activation in MB, here we present preclinical and molecular data on the effects of two novel classes of PP2A activators on disease processes of LMD in group 3 MB. The PP2A activators used in this study are ATUX-6156 and ATUX-6954 (diarylmethylcycloamine sulfonylureas), and ATUX-1215 and ATUX-5800 (diarylmethyl-4-aminotetrahydropyran-sulfonamides). Treatment with these compounds led to suppression of the endogenous PP2A inhibitor, cancerous inhibitor of PP2A (CIP2A), enhanced phosphatase activity (10-60%), and reduced MB viability, migration, and invasion, prerequisites for MB cells to access the cerebrospinal fluid, affecting the initiation stage of LMD. PP2A activator treatment of MB cells led to apoptosis mediated via caspase 9/PARP signaling due to decreased phosphorylation of Bad, impeding the dispersal stage of LMD. Cell proliferation and LMD-driving cellular traits and molecules pertinent to the third stage, colonization, were also affected. Treatment with ATUX-1215 or ATUX-5800 prevented LMD in an intraventricular murine model of MB, possibly mediated by disruption of the CCL2-CCR2 axis by altered NF-kB phosphorylation via disrupted AKT signaling. The present investigation offers proof-of-principle data for PP2A-based reactivation therapy for Group 3 MB and provides the first indications that PP2A reactivation may challenge the current paradigm in targeting the 3-stage process of MB LMD. Further investigations of PP2A activators are warranted as these compounds may prove beneficial as therapeutics for MB.",
    "authors": [
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Nazia",
            "initials": "N",
            "lastname": "Nazam"
        },
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Michael H",
            "initials": "MH",
            "lastname": "Erwin"
        },
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Janet R",
            "initials": "JR",
            "lastname": "Julson"
        },
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Colin H",
            "initials": "CH",
            "lastname": "Quinn"
        },
        {
            "affiliation": "Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Andee M",
            "initials": "AM",
            "lastname": "Beierle"
        },
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Laura V",
            "initials": "LV",
            "lastname": "Bownes"
        },
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Jerry E",
            "initials": "JE",
            "lastname": "Stewart"
        },
        {
            "affiliation": "Division of Hematology Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Kyung-Don",
            "initials": "KD",
            "lastname": "Kang"
        },
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Swatika",
            "initials": "S",
            "lastname": "Butey"
        },
        {
            "affiliation": "Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.",
            "firstname": "Elizabeth",
            "initials": "E",
            "lastname": "Mroczek-Musulman"
        },
        {
            "affiliation": "Atux-Iskay, LLC, Plainsboro, New Jersey, USA.",
            "firstname": "Michael",
            "initials": "M",
            "lastname": "Ohlmeyer"
        },
        {
            "affiliation": "Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: elizabeth.beierle@childrensal.org.",
            "firstname": "Elizabeth A",
            "initials": "EA",
            "lastname": "Beierle"
        }
    ],
    "conclusions": null,
    "copyrights": "Copyright \u00a9 2024 The Authors. Published by Elsevier Inc. All rights reserved.",
    "doi": "10.1016/j.jbc.2024.107892\n10.1101/2022.05.31.494146",
    "journal": "The Journal of biological chemistry",
    "keywords": [
        "PP2A",
        "diarylmethyl cycloamine sulfonylureas",
        "leptomeningeal dissemination",
        "medulloblastoma",
        "pyran sulfonamides"
    ],
    "methods": null,
    "publication_date": "2024-10-18",
    "pubmed_id": "39419284\n33538338\n22134537\n27238212\n26976201\n31621042\n30771762\n18329957\n33827975\n29720672\n29031806\n35454859\n32954276\n37458534\n32494160\n33400072\n28938602\n37011459\n37526463\n37974628\n34241636\n20182580\n26885690\n17039417\n28609654\n30810905\n35364610\n34145035\n36854761\n27775079\n22351749\n11181042\n29299124\n19701246\n31185958\n16707597\n22843885\n26557719\n30842251\n29474906\n37323483\n33200034\n36497454\n30021885\n27671680\n30132166\n26188016\n2535715\n1904513\n27547779\n22307474\n34012702",
    "results": null,
    "title": "PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastoma.",
    "xml": "<Element 'PubmedArticle' at 0x788503f491c0>"
}